ANGO vs IQV · rev $292.5M vs P/E 23, rev $15.40B
AngioDynamics Inc (ANGO) versus IQVIA Holdings Inc (IQV) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
IQVIA Holdings Inc (IQV) is a diagnostics & research company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported IQV revenue for 2024-12-31 was $15.40B. Net income was $1.37B. Revenue was up 2.8% from 2023-12-31 to 2024-12-31. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
ANGO currently screens at market cap $378.5M. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
Not investment advice. Open the ANGO and IQV stock pages for the full models.
Not investment advice.